Sex hormone patterns in women with multiple sclerosis as related to disease activity - a pilot study;Profil hormonalny u kobiet chorych na stwardnienie rozsiane w powiązaniu z aktywnością choroby - doniesienie wstępne

Neurologia i Neurochirurgia Polska

Volumn 45, Issue 6, 2011, Pages 536-542

  Zakrzewska Pniewska, Beata ^a   Gołebiowski, Marek ^a   Zajda, MaŁgorzata ^a   Szeszkowski, Wojciech ^a   Podlecka Pietowska, Aleksandra ^a   Nojszewska, Monika ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

MRI; Multiple sclerosis; Sex hormones

Indexed keywords

ESTRADIOL; PROGESTERONE; PROLACTIN;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; DEMYELINATION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; HYPOTHALAMUS LESION; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; RELAPSE; SCORING SYSTEM;

EID: 84855310868     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/S0028-3843(14)60120-1     Document Type: Article

References (42)

1. Bashir K., Whitaker J.N. Clinical and laboratory features of primary progressive and secondary progressive MS. Neurology 1999; 53: 765-771.
2. Duquette P., Pleines J., Girard M., et al. The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992; 19: 466-471.
3. Whitacre C.C., Reingold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999; 283: 1277-1278.
4. van den Broek H.H., Damoiseaux J.G., de Baets M.H., et al. The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encepha-lomyelitis; a revue. Mult Scler 2005; 11: 349-359.
5. Peltrey C.M., Moldovan I.R., Cotleur A.C., et al. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis. J Neuroimmunol 2005; 167: 190-203.
6. El-Etr M., Vukusic S., Gignoux L., et al. Steroid hormones in multiple sclerosis. J Neurol Sci 2005; 233: 49-54.
7. Kim S., Liva S.M., Dalal M.A., et al. Estriol ameliorates autoimmune demyelinating disease. Implications for multiple sclerosis. Neurology 1999; 52: 1230-1238.
8. Shuster E.A. Hormonal influences in multiple sclerosis. Curr Top Microbiol Immunol 2008; 318: 267-311.
9. Smith R., Studd J.W. The pilot study of the effect upon multiple sclerosis of the menopause, hormone replacement therapy and menstrual cycle. J R Soc Med 1992; 85: 612-613.
10. Zorgdrager A., de Keyser J. Premenstrual exacerbations of multiple sclerosis. J Neurol Neurosurg Psychiatry 1998; 65: 279-280.
11. Zorgdrager A., de Keyser J. Menstrually related worsening of symptoms in multiple sclerosis. J Neurol Sci 1997; 149: 95-97.
12. Hernan M.A., Hohol M.J., Olek M.J., et al. Oral contraceptives and incidence of multiple sclerosis. Neurology 2000; 55: 848-853.
13. Voskuhl R.R., Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 2001; 7: 258-270.
14. Correale J., Arias M., Gilmore W. Steroid hormone regulation of cytokine secretion by proteolipid-specific CD4+ T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1998; 161: 3365-3374.
15. Elenkov I.J., Wilder R.L., Bakalov V.K., et al. IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86: 4933-4938.
16. Dudley D.J., Chen C.L., Mitchell M.D., et al. Adaptative immune responses during murine pregnancy: pregnancy-induced regulation of lymphokines production by activated T lymphocytes. Am J Obstet Gynecol 1993; 168: 1155-1163.
17. Wegmann T.G., Lin H., Guilbert L., et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol Today 1993; 14: 353-356.
18. McDonald I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
19. Palaszynski K.M., Liu H., Loo K.K., et al. Estriol treatment ameliorates disease in males with experimental autoimmune encepha - lomyelitis: implications for multiple sclerosis. J Neuro immunol 2004; 149: 84-89.
20. Rijhsinghani A.G., Thompson K., Bhatia S.K., et al. Estrogen blocks early T cell development in the thymus. Am J Reprod Immunol 1996; 36: 269-277.
21. Carlsten H., Holmdahl R., Tarkowski R., et al. Oestradiol- and testosterone-mediated effects on the immune system in normal and autoimmune mice are genetically linked and inherited as dominant traits. Immunology 1989; 68: 209-214.
22. Nilsson N., Carlsten H. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation. Cell Immunol 1994; 158: 131-139.
23. Josefsson E., Tarkowski A., Carlsten H. Anti-inflammatory properties of estrogen. In vivo suppression of leukocyte production in bone marrow and redistribution of peripheral blood neutrophiles. Cell Immunol 1992; 142: 67-78.
24. Vukusic S., Confavreux C. Pregnancy and multiple sclerosis: The children of PRIMS. Clin Neurol Neurosurg 2006; 108: 266-270.
25. Derw P.D., Chavis J.A. Female sex steroids: effects upon micro glial cell activation. J Neuroimmunol 2000; 111: 77-85.
26. Hellwig K., Beste C., Brune N., et al. Increased MS relapse rate during assisted reproduction technique. J Neurol 2008; 255: 592-593.
27. Confavreux C., Hutchinson M., Hours M.M. Rate of pregnancy- related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339: 285-291.
28. van Walderveen M.A., Tas M.W., Barkhof F., et al. Magnetic resonance evaluation of disease activity during pregnancy in multiple sclerosis. Neurology 1994; 44: 327-329.
29. Antulov R., Weinstock-Guttman B., Cox L.J., et al. Genderrelated differences in MS: a study of conventional and nonconventional MRI measures. Mult Scler 2009; 15: 345-354.
30. Bansil S., Lee H.J., Jindal S., et al. Correlation between sex hormones and magnetic resonance imaging lesions in multiple sclerosis. Acta Neurol Scand 1999; 99: 91-94.
31. Thomson D.S., Nelson L.M., Burns A., et al. The effects of pregnancy in multiple sclerosis: a retrospective study. Neurology 1986; 36: 1097-1099.
32. van Zeben D., Hazes J.M., Vandenbroucke J.P., et al. Diminished incidence of severe rheumatoid arthritis associated with oral contraceptives use. Arthritis Rheum 1990; 33: 1462-1465.
33. Vandenbroucke J.P., Witteman J.C., Valkenburg H.A., et al. Noncontraceptive hormones and rheumatoid arthritis in perimenopausal and postmenopausal women. JAMA 1986; 255: 1299-1303.
34. Hazes J.M., Dijkmans B.A., Vandenbroucke J.P., et al. Oral contraceptive treatment for rheumatoid arthritis: an open study in 10 female patients. Br J Rheumatol 1989; 28 (Suppl 1): 28-30.
35. Hernandez-Avila M., Liang M.H., Willet W.C., et al. Exogenous sex hormones and the risk of rheumatoid arthritis. Arthitis Rheum 1990; 33: 947-953.
36. Hernan M.A., Hohol M.J., Olek M.J., et al. Oral contraceptives and the incidence of multiple sclerosis. Neurology 2000; 55: 848-854.
37. Ehrlich S., Haas J., Zipp F., et al. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy. J Neurol Sci 2007; 252: 83-87.
38. Acs P., Kipp M., Norkute A., et al. 17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice. Glia 2009; 57: 807-814.
39. Garay L., Gonzalez-Deniselle M.C., Gierman L., et al. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 2008; 15: 76-83.
40. Pozzilli C., Falaschi P., Mainero C., et al. MRI in multiple sclerosis during the menstrual cycle: relationship with sex hormones patterns. Neurology 1999; 53: 622-624.
41. Weatherby S.J., Mann C.L., Davies M.B. A pilot study of the relationship between gadolinium-enhancing lesions, gender effect and polymorphisms of antioxidant enzymes in multiple sclerosis. J Neurol 2000; 247: 467-470.
42. Horsfield M.A. Magnetization transfer imaging in multiple sclerosis. J Neuroimaging 2005; 15: 58S-67S.